Chlamydiae depend heavily on their host cells for energy and essential nutrients, including amino acids and nucleoside triphosphates. Unlike species of the bacterial parasites Shigella, Listeria, and Rickettsia, which have direct access to the nutrient-rich environment of the host cytoplasm (8, 20, 21) , chlamydiae are sequestered in a membrane-bound vacuole, termed an inclusion. Living within a vacuole presents some unique challenges not faced by organisms in the cytoplasm. One of these challenges includes the acquisition of nutrients from the host cell. Heinzen and Hackstadt (6) showed that the inclusion membrane is not passively permeable to molecules as small as 520 Da by microinjection studies of fluorescent tracer molecules. Therefore, nutrient acquisition is likely mediated through transport mechanisms at the inclusion membrane.
Another key to chlamydial pathogenesis and survival is their ability to avoid fusion with lysosomal compartments in order to persist and replicate within the host cell. Several experiments have shown the mature chlamydial inclusion to be nonfusogenic with markers from the endosomal-lysosomal pathway. Electron microscopic analysis showed that ferritin-labeled lysosomes do not fuse with the inclusion (23) . Neither fluidphase markers nor markers of the early or late endosomes are associated with the chlamydial inclusion (7, 15, 19) . However, chlamydiae do sequester and modify host cell lipids and apparently reside in an exocytic arm of the host vesicular trafficking network (4, 5, 22) . Modification of the vesicle to intersect an exocytic pathway requires chlamydial protein synthesis, which suggests that the chlamydiae synthesize proteins that determine the vesicular interactions of the inclusion (16) .
It is thought that both acquisition of nutrients and avoidance of lysosomal fusion may be mediated by chlamydial proteins secreted into the inclusion membrane. This led to the identification and characterization of IncA, a Chlamydia psittaci protein that is present uniquely in infected cells, is localized to the inclusion membrane (12) , is exposed to the host cell cytoplasm, and is phosphorylated by the host cell (13) . Two additional inclusion membrane proteins, termed IncB and IncC, were recently identified in C. psittaci (1) .
Despite considerable effort, incA, incB, and incC were never detected in Chlamydia trachomatis by conventional laboratory methods. The failure of these approaches led to the concern that C. psittaci IncA, IncB, and IncC might not directly model inclusion development in the human pathogenic species of the chlamydiae. With the completion of the C. trachomatis genome project (17) , incA has been identified in this species. This report describes our characterization of IncA from C. trachomatis.
Organisms. C. trachomatis
LGV-434, serovar L2, and C. trachomatis serovar D were cultivated in HeLa 229 cells as previously described ( Antiserum production. A maltose-binding protein (MBP)-IncA fusion protein was produced by using the pMAL-c2 vector system from New England Biolabs as described previously (1) . C. trachomatis serovar D incA was amplified with 5Ј-AG CCATAGGATCTGGTTTCAGCGA-3Ј and 5Ј-GCGCGGAT CCTAGGAGCTTTTTGTAGAGGGTGA-3Ј and then cloned into pMAL-c2.
MBP-IncA was used as antigen for the production of monospecific antibody in New Zealand White rabbits (12) . Antiserum against C. trachomatis serovar L2 was produced in cynomolgus monkeys (Macaca fascicularis). Monkeys were anesthetized and infected urethrally with C. trachomatis elementary bodies (EBs) three times over the course of 6 months. Symptoms of infection were monitored over time. Antisera from infected monkeys were tested for reactivity to chlamydiae by enzyme-linked immunosorbent assay (reference 18 and unpublished data) and immunoblotting. Human sera that demonstrated high titers of antibody to C. trachomatis or Chlamydia pneumoniae by microimmunofluorescence assay were selected from stored serum specimens at the University of Washington. Negative control antisera were taken from pa-tients who had no detectable reactivity by microimmunofluorescence against any of the C. trachomatis serovars listed above or C. pneumoniae TWAR. Antilipopolysaccharide monoclonal antibody was produced as described previously (2) .
Immunoblotting and immunofluorescence microscopy. Polyacrylamide gel electrophoresis and immunoblotting were performed as previously described (11, 12) . Chlamydiae grown in HeLa cells on sterile glass coverslips were methanol fixed 30 h postinfection and stained as previously described (12) . Immunostained coverslips were visualized with the 63ϫ objective of a Zeiss microscope equipped with an epifluorescence condenser and an MC 63 C photomicrographic camera.
Sequence analysis of C. trachomatis incA. All sequence analysis was conducted by using methods described by Bannantine et al. (1) . C. trachomatis incA was identified by limited homology in the C. trachomatis genome sequence database (17) . A BLAST search of the amino acid sequence showed C. psittaci IncA to be the strongest match in the database, but that match was weak, with an E value of only 2 ϫ 10
Ϫ5
. The 30-kDa size of IncA from C. trachomatis is smaller than that of C. psittaci IncA, and their identity and similarity were only 21 and 41%, respectively. Weak homology at the nucleotide sequence level explained why C. trachomatis incA was not detected by Southern hybridization or PCR amplification with probes and prim- ers from the C. psittaci genomic sequence. Although IncA sequence identity between C. trachomatis and C. psittaci is low, comparison of their hydropathy plots shows similar large hydrophobic regions near the N-terminal ends (Fig. 1) . Such a long hydrophobic region, with its unique bilobed shape, may be useful in predicting other chlamydial proteins in the inclusion membrane since it is also present in IncB and IncC (1). The location of the hydrophobic domain is near the C-terminal end in IncB and IncC. To show that this hydrophobic domain is not fortuitous, several open reading frames (ORFs) identified in the C. trachomatis genome project have been screened by hydropathy plot analysis, and only tested ORFs that encode proteins with similar secondary structure are localized to the inclusion membrane (13a). Primers were designed from the serovar D incA sequence, and they amplified incA from serovar L2 as well as D. The sequence from these two serovars is highly conserved: only 5 of 273 amino acids are different. The same primers did not amplify a product with C. pneumoniae genomic DNA as a template.
The region surrounding incA is not conserved between C. trachomatis and C. psittaci. In previous work, we and others have isolated four independent C. psittaci genomic clones that collectively define a group of four physically linked genes as shown in Fig. 2 (12, 13a) . The completion of the C. trachomatis genome sequence has allowed a comparison of the arrangement of these genes in C. psittaci and C. trachomatis. Each of the four ORFs is present in the C. trachomatis genome, but the physical linkage has been disrupted. In C. psittaci, incA is immediately upstream of an ORF designated GPIC133 (Fig. 2) , with an intergenic region of 157 bp (see orf2 in reference 12). ORF 133 is present in both C. psittaci and C. trachomatis and is relatively conserved, with 58% identity between the deduced amino acid sequences. The incA coding sequence in C. trachomatis is downstream and separated from ORF 133 (D133) by 12,678 bp, with incA located at contig 2.3 in the genome and D133 located at contig 2.5. Note the scale difference between the two genomic segments in Fig. 2 . Immunoblot analysis of infected cells and purified C. trachomatis EBs was performed with rabbit anti-MBP-IncA as a probe. A 27-kDa band was present only in the infected cells and not in lysates of EBs or uninfected cells (data not shown).
In order to determine if IncA was recognized by sera from convalescent animals and humans, purified MBP-IncA fusion protein was loaded onto a preparative sodium dodecyl sulfatepolyacrylamide gel and used to examine reactivity with sera from patients and monkeys infected with C. trachomatis. The majority of the sera from chlamydia-infected patients (10 of 11) and all monkey convalescent-phase sera recognized the IncA protein (Fig. 3A) but not the MBP portion of the fusion (Fig. 3B) . IncA was faintly recognized by sera from one of the C. pneumoniae-infected patients (Fig. 3A, lane 1) .
Antisera against IncA and a monoclonal antibody against chlamydial lipopolysaccharide were used to immunostain methanol-fixed layers of C. trachomatis-infected HeLa cells. Anti-IncA reacted with the membrane of the inclusion but not the chlamydial developmental forms (Fig. 4A to C) . Antigenic fibers extending away from the inclusion, which are similar in structure to those found in C. psittaci-infected cells (12) , were also present in C. trachomatis-infected cells (Fig. 4B to D) . Their function and origins remain unknown. Also evident in Fig. 4B and C are antigenic fibers that traverse between otherwise apparently separate cells. It is likely that these are daughter cells in which inclusions can either divide with the dividing cell (10) or stay in one daughter cell and leave the other uninfected. C. psittaci IncA can also be found in fibers that extend between pairs of infected cells (data not shown). One major difference between these two processes is that in C. psittaci (strain GPIC), each daughter cell usually remains infected. In C. trachomatis, however, uninfected progeny cells are common. Because IncA is also found in fibers that extend to the uninfected daughter cells (Fig. 4B and C) , the result is a cell lacking chlamydial developmental forms but containing chlamydial antigen.
In addition to the LGV biovar strain (serovar L2) shown in Fig. 4 , several other C. trachomatis serovars of clinical interest were analyzed by immunofluorescence microscopy for staining with anti-MBP-IncA (Table 1) . Anti-MBP-IncA labeled the inclusion membranes of all serovars tested.
The inclusion membrane mediates all contact between the host cell and chlamydiae; therefore, the acquisition of nutrients and the nonfusogenic nature of the chlamydial inclusion may be elucidated by studying chlamydial proteins that reside in the inclusion membrane. Because the routing of transport vesicles throughout the cell is mediated by proteins present on the transport vesicle membrane (14) , IncA as well as IncB and IncC are excellent candidate proteins for mediating inclusion trafficking within infected cells. We undertook these studies to define the presence and intracellular location of IncA in all of the major C. trachomatis serovars and to assess whether an antibody response to IncA was present in infected patients and primates. We speculate that C. pneumoniae also produces Inclike proteins and are initiating an investigation into this system. Finally, we continue to pursue questions surrounding the role of the Inc proteins in the chlamydial infection process as well as their role as possible protective antigens in the host response to chlamydial infection.
Nucleotide sequence accession number. The nucleotide sequence of C. trachomatis LGV-434, serotype L2, incA has been deposited in the GenBank database under accession no. AF067958.
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